{"entity":{"type":"insider","cik":"0001454983","url":"/insider/0001454983","json_url":"/insider/0001454983.json","name":"Levy Richard S","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":110,"n_filings":45,"first":"2010-03-17","last":"2026-05-22","span_basis":"filed_date"},"name_variants":[{"name":"Levy Richard S","source":"filing","n_filings":45,"first_seen":"2010-03-17","last_seen":"2026-05-22"}],"transactions":[{"id":5757403,"accession":"0001628280-26-037830","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001628280-26-037830","line_url":"/filing/0001628280-26-037830","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001454983","owner_name":"Levy Richard S","owner_display_name":"Levy Richard S","owner_url":"/insider/0001454983","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5682.0,"shares_display":"5,682","price_per_share":515.4375973952833,"price_display":"515.44","price_state":"stated","total_value":2928716.4284,"total_display":"2,928,716.43","total_whole":"2,928,716","shares_owned_after":22877.0,"shares_owned_after_display":"22,877","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-22","filed_date":"2026-05-22","scope":"insider","n_lines":12},{"id":4889127,"accession":"0001628280-25-052411","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001628280-25-052411","line_url":"/filing/0001628280-25-052411","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001454983","owner_name":"Levy Richard S","owner_display_name":"Levy Richard S","owner_url":"/insider/0001454983","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":520.9644195411764,"price_display":"520.96","price_state":"stated","total_value":4428197.5661,"total_display":"4,428,197.57","total_whole":"4,428,198","shares_owned_after":22961.0,"shares_owned_after_display":"22,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-13","filed_date":"2025-11-14","scope":"insider","n_lines":14},{"id":9273108,"accession":"0001213900-25-045399","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-25-045399","line_url":"/filing/0001213900-25-045399#line-1","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001454983","owner_name":"Levy Richard S","owner_display_name":"Levy Richard S","owner_url":"/insider/0001454983","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":3.19,"price_display":"3.19","price_state":"stated","total_value":63800.0,"total_display":"63,800.00","total_whole":"63,800","shares_owned_after":51000.0,"shares_owned_after_display":"51,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-14","filed_date":"2025-05-19","scope":"insider"},{"id":4231516,"accession":"0001213900-25-044871","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-25-044871","line_url":"/filing/0001213900-25-044871#line-1","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001454983","owner_name":"Levy Richard S","owner_display_name":"Levy Richard S","owner_url":"/insider/0001454983","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":3.19,"price_display":"3.19","price_state":"stated","total_value":63800.0,"total_display":"63,800.00","total_whole":"63,800","shares_owned_after":51000.0,"shares_owned_after_display":"51,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-14","filed_date":"2025-05-16","scope":"insider"},{"id":2952116,"accession":"0000950170-24-124232","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-124232","line_url":"/filing/0000950170-24-124232#line-2","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001454983","owner_name":"Levy Richard S","owner_display_name":"Levy Richard S","owner_url":"/insider/0001454983","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":350.0,"price_display":"350.00","price_state":"stated","total_value":1750000.0,"total_display":"1,750,000.00","total_whole":"1,750,000","shares_owned_after":11012.0,"shares_owned_after_display":"11,012","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-07","filed_date":"2024-11-08","scope":"insider"},{"id":2039807,"accession":"0000950170-24-121722","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-24-121722","line_url":"/filing/0000950170-24-121722","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001454983","owner_name":"Levy Richard S","owner_display_name":"Levy Richard S","owner_url":"/insider/0001454983","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":300.940682,"price_display":"300.94","price_state":"stated","total_value":1504703.41,"total_display":"1,504,703.41","total_whole":"1,504,703","shares_owned_after":13212.0,"shares_owned_after_display":"13,212","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-01","filed_date":"2024-11-05","scope":"insider","n_lines":4},{"id":3109642,"accession":"0000950170-24-041528","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000950170-24-041528","line_url":"/filing/0000950170-24-041528","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001454983","owner_name":"Levy Richard S","owner_display_name":"Levy Richard S","owner_url":"/insider/0001454983","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":257.48496406363637,"price_display":"257.48","price_state":"stated","total_value":2832334.6047,"total_display":"2,832,334.60","total_whole":"2,832,335","shares_owned_after":16911.0,"shares_owned_after_display":"16,911","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider","n_lines":6},{"id":7833921,"accession":"0000899243-23-002219","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000899243-23-002219","line_url":"/filing/0000899243-23-002219","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001454983","owner_name":"Levy Richard S","owner_display_name":"Levy Richard S","owner_url":"/insider/0001454983","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22489.0,"shares_display":"22,489","price_per_share":293.15156520965803,"price_display":"293.15","price_state":"stated","total_value":6592685.55,"total_display":"6,592,685.55","total_whole":"6,592,686","shares_owned_after":20637.0,"shares_owned_after_display":"20,637","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-19","scope":"insider","n_lines":10},{"id":2468403,"accession":"0001209191-20-020949","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-020949","line_url":"/filing/0001209191-20-020949#line-2","is_derivative":false,"issuer_cik":"0001454983","issuer_name":"Kodiak Sciences Inc.","issuer_ticker":"KOD","issuer_name_source":null,"issuer_url":"/issuer/0001454983","owner_cik":"0001454983","owner_name":"Levy Richard S","owner_display_name":"Levy Richard S","owner_url":"/insider/0001454983","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":750.0,"shares_display":"750","price_per_share":44.65,"price_display":"44.65","price_state":"stated","total_value":33487.5,"total_display":"33,487.50","total_whole":"33,488","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-20","filed_date":"2020-03-24","scope":"insider"}],"collapsed":true,"next_cursor":"2020-03-20|2468403","ledger_fault":false,"count":{"value":110,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":24,"open_market":true},{"code":"S","label":"Open-market sale","n":86,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":110},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001157601","name":"MADRIGAL PHARMACEUTICALS, INC.","url":"/issuer/0001157601","role":"Director","n_filings":9,"first_seen":"2017-08-22","last_seen":"2026-05-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001359931","name":"Protara Therapeutics, Inc.","url":"/issuer/0001359931","role":"Director","n_filings":2,"first_seen":"2025-05-16","last_seen":"2025-05-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001468748","name":"Kodiak Sciences Inc.","url":"/issuer/0001468748","role":"Director","n_filings":1,"first_seen":"2020-03-24","last_seen":"2020-03-24"},{"type":"issuer","type_label":"ISSUER","cik":"0000879169","name":"INCYTE CORP","url":"/issuer/0000879169","role":"Officer (EVP, Chief Drug Dev Officer)","n_filings":33,"first_seen":"2010-03-17","last_seen":"2016-01-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001454983","retrieved_at":"2026-08-23T09:41:59+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}